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Introduction
Patients that are suspected of neoplastic lung disease 
require an accurate tissue diagnosis in order for an optimal 
treatment to be selected and applied. This diagnosis 
is usually prepared through percutaneous sampling. 
Improvements in radiological techniques have led to 
the identification of relatively small lesions, which are 
required as a guide to obtaining qualitative specimens. 
Transthoracic fine needle aspiration (FNA) cytology 
and core needle biopsy (CNB) are two commonly used 
methods for obtaining diagnostic material. FNA specimens 
are often acquired using 20-25 gauge needles, and these 
generally provide a sample for cytological examination, 
whereas CNB specimens are obtained using larger 14-18 
gauge needles and they primarily provide a tissue core for 
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Abstract
 Background: Transthoracic fine needle aspiration (FNA) cytology and core needle biopsy (CNB) are two 
commonly used approaches for the diagnosis of suspected neoplastic intrathoracic lesions. This study compared 
the diagnostic accuracy of FNA cytology and concurrent CNB in the evaluation of intrathoracic lesions. Materials 
and Methods: We studied FNA cytology and concurrent CNB specimens of 127 patients retrospectively, using 
hematoxylin and eosin (H&E), immunohistochemistry, and, on certain occasions cytochemistry. Information 
regarding additional tissue tests was derived from the electronic archives of the Department of Pathology and 
Laboratory Medicine as well as patient records. Diagnostic accuracy was calculated for each test. Results: Of 127 
cases, 22 were inconclusive and excluded from the study. The remaining 105 were categorized into 73 (69.5%) 
malignant lesions and 32 (30.5%) benign lesions. FNA and CNB findings were in complete agreement in 63 cases 
(60%). The accuracy and confidence intervals (CIs) of FNA and CNB for malignant tumors were 86.3% (CI: 
79.3-90.7) and 93.2% (CI: 87.3- 96.0 ) respectively. For epithelial malignant neoplasms, a definitive diagnosis was 
made in 44.8% of cases by FNA and 80.6% by CNB. The diagnostic accuracy of CNB for nonepithelial malignant 
neoplasms was 83.3% compared with 50% for FNA. Of the 32 benign cases, we made specific diagnoses in 16 
with diagnostic accuracy of 81.3% and 6.3% for CNB and FNA, respectively. Conclusions: Our findings suggest 
that FNA is comparable to CNB in the diagnosis of malignant epithelial lesions whereas diagnostic accuracy of 
CNB for nonepithlial malignant neoplasms is superior to that for FNA. Further, for histological typing of tumors 
and examining tumor origin, immunohistochemical work up plays an important role. 
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histological assessment.
Each method offers different advantages and 
limitations. FNA is a simple and cost-effective method 
that provides valuable information. However, FNA 
specimens can be difficult to interpret in cases where 
there is a small sample, high sampling error, or a lack of 
a histological pattern (Hajdu et al., 1984). FNA sensitivity 
and accuracy are therefore positively affected by the 
presence of a cytopathologist on site during the biopsy 
procedure. Immediate assessment of the adequacy and 
quality of the sample also helps reduce the number of 
false negative results (Stewart et al., 1996; Nasuti et 
al., 2002; Wallace et al., 2004). CNB is more sensitive 
when defining benign lung lesions. Moreover, it is more 
accurate at characterizing lymphoproliferative diseases 
and subtyping malignancies, where the assessment of 
Arezoo Eftekhar-Javadi et al
Asian Pacific Journal of Cancer Prevention, Vol 16, 20157386
tissue architecture is crucial to the diagnosis (Sagel et al., 
1978; Kim et al., 2002). However, CNB is more invasive 
and although considered to be generally safe, it may be 
associated with increased complications (Norenberg et 
al., 1974; Arnold et al., 2002).
There are conflicting data in the literature regarding 
the accuracy and usefulness of these techniques for the 
evaluation of intrathoracic lesions (Bocking et al., 1995; 
Arakawa et al., 1996; Greif et al., 1999; Nasuti et al., 2002; 
Kravtsov et al., 2014). Most previous reports present a 
limited number of cases and few studies have directly 
compared these two methods when treating the same 
patient (Gong et al., 2006). The purpose of this study was 
to compare the diagnostic accuracy of concurrent FNA and 
CNB of intrathoracic lesions in order to obtain reliable data 
on the advantages and disadvantages of each technique.
Materials and Methods
From October 2008 to September 2010, 127 patients at 
our center underwent sequential percutaneous computed 
tomography (CT)-guided FNA and CNB procedures 
for evaluation of intrathoracic lung lesions. The study 
was conducted with the approval of institutional review 
committees. Clinical and radiological information for 
these patients was made available for review. 98 out 
of 105 lesions were pulmonary lesions, five lesions 
involved thoracic wall and pulmonary parenchyma and 
the remaining two lesions were mediastinal.
Transthoracic CT-guided FNA was performed using 
a 20- or 22-gauge aspirating needle through a coaxial 
18-gauge guide needle (Cook, Bloomington, IN). Two 
or three FNA passes were usually made. Direct smears 
were air-dried for Wright staining or fixed in 95% ethanol 
for Papanicolaou staining. An on-site pathologist was 
available for immediate assessment of specimen adequacy 
and triage the specimen for additional studies, including 
to send fresh sample to microbiology laboratory and 
tuberculosis referral center for culture, staining and if 
indicated PCR studies. In our study, an aspirate sample was 
considered to be inadequate if it was unrepresentative (i.e., 
markedly hypocellular, contained only blood, normal lung 
parenchyma and histiocytes). The subsequent cytological 
diagnosis was based on the cytomorphological features 
of the smears and special stains for microorganisms 
such as acid-fast stain for mycobacteria, nocardia and 
actinomycetes, Methanamine silver and PAS for fungi 
and Gram stain for Bacteria. Stainings were performed 
on previously prepared unstained smears if available. 
CNB was performed in all cases using a 20-gauge, 
coaxial, automated cutting needle biopsy system 
(Cook). Two to four cores were usually obtained. The 
core biopsy specimen was transferred to 10% buffered 
formalin fixative. The formalin-fixed core tissues were 
embedded in paraffin, sectioned, and stained with H&E. 
Immunohistochemical stains were applied on all CNB 
samples from cases with malignant lesions using a panel 
including CK7, CK20, p63, TTF-1 and CDX2 in order 
to define histologic types and origin of the tumoral 
cells (i.e. primary tumor versus metastatic ). Additional 
markers (such as synaptophysin, chromogranin A, 
CD99, CD45 and etc.) were used in next steps based on 
histomorphological and immunohistochemical findings. 
Special stains were performed when indicated.
Two pathologists, who were not aware of the reported 
results in advance, assessed FNA and CNB samples 
independently. In other words, for blind randomization 
purposes, they were not able to extrapolate the results 
of FNA samples toward CNB samples or vice versa. 
The major diagnostic categories for FNA and CNB were 
malignant, indeterminate or atypical (when cytologic 
smears had atypical cells which didn’t full-fill the criteria 
of malignancy or histologic sections mainly formed by 
necrotic tissue containing few atypical cells in between), 
negative for malignancy (NFM)-benign specific lesions, 
NFM- non-specific lesion (specimens with non-specific 
inflammation and/or fibrosis), inadequate. For cases 
classified as positive for malignancy, an attempt was 
made to determine the histological type, to understand 
whether it was a primary or metastatic lesion, and, if it 
was a metastasis, to specify its origins.
In cases of benign lesions, if the pathological findings 
were compatible with the radiological and clinical 
impressions, then these were defined as benign-specific 
lesions; this group included lesions such as granulomatous 
lesions, bronchiolitis obliterans organizing pneumonia, 
organizing bacterial pneumonia and hydatid cysts. If 
biopsy material comprised only normal parenchyma, 
fibrosis or non-specific inflammation, then it was classified 
as a benign non-specific lesion.
The diagnostic accuracy of each modality and the 
combination of both was assessed by comparing the initial 
diagnosis with the final diagnosis of the lesion. The final 
diagnosis was made by a combination of information from 
resected specimen revisions (in five cases) and/or definitive 
biopsy diagnosis (FNA and CNB) with consideration of 
immunohistochemical results, clinical and radiological 
data, microbiologic studies, follow up data and response 
to treatment modalities. All cases with final diagnoses of 
malignancy had unequivocal pathological findings. For 
those cases with diagnosis of “ benign-nonspecific lesion” 
a follow-up studies were carried out for at least one year 
in order to rule out undiagnosed malignancy or specific 
benign lung lesions or masses.
Results 
Of 127 cases included in the study 22 cases were 
excluded from further analysis because of lack of enough 
histologic and cytological material and/or radiologic or 
clinical evidence to determine the nature of the lesions. Of 
105 cases that constituted the final cohort 63 (60%) were 
male and 42 (40%) were female. Median age for all 105 
cases was 65 years (63 years for females and 65.5 years 
for males).The occurrence of lung lesions was higher in 
left lower lobe and right upper lobe. Location of mass did 
not affect the FNA or CNB results. Malignant tumors were 
diagnosed in 73 (69.5%) and benign lesions in 32 (30.5%) 
cases. Among these 105 cases, FNA and CNB findings 
were in complete agreement in 63 cases (60%), 39 of 
which were malignant and 24 were benign. Among the 73 
malignant cases, 59 were primary epithelial tumors (five 
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were small cell “neuroendocrine” carcinomas, 27 were 
adenocarcinomas, 24 were SCC, one typical carcinoid and 
two atypical carcinoids), eight were metastatic carcinomas 
( six from colon and two from breast)and six were non-
epithelial (two Hodgkin lymphomas, two sarcomas and 
two primitive neuroectodermal tumors) (Table 1). The 
indeterminate/atypical diagnosis was made in 9.5% (n=10) 
and 3.8% (n=4) of FNA and CNB cases, respectively. 
The overall diagnostic accuracy rates of FNA, CNB 
and both are summarized in Table 2. The accuracy of 
FNA and CNB for malignant tumors was 86.3% and 
93.2%, respectively. The 95% confidence interval for 
FNA was 79.25- 90.65 and for CNB was 87.33- 95.95. 
For epithelial malignant neoplasms, definitive diagnosis 
was made in 30 out of 67 (44.8%) cases by FNA and 54 
out of 67 (80.6%) cases by CNB. Within this group, FNA 
and CNB had similar typing accuracy rates for small 
cell “neuroendocrine” carcinoma. CNB showed better 
results for all other types of epithelial neoplasms. But the 
atypical carcinoid cases were erroneously diagnosed as 
non-small cell carcinoma and squamous cell carcinoma 
in FNA and CNB, respectively. Interestingly, a single 
primary adenocarcinoma case was diagnosed in FNA only. 
All four indeterminate/atypical CNB cases underwent 
surgical resection which had squamous cell carcinoma in 
histopathologic examination. For non-epithelial malignant 
neoplasms, CNB also yielded better diagnostic accuracy 
than FNA (83.3% vs 50%, respectively). It is notable that 
neither of both sarcoma cases was diagnosed by FNA. In 
addition, one out of two primitive neuroectodermal tumors 
(PNET) which was misclassified as small cell carcinoma 
by CNB before application of immunohistochemical 
panel. It is noteworthy that both PNET cases were 
classified as small round malignant tumor by FNA and 
combination of two methods increased the accuracy of 
diagnosis (Table 1) (Figure 1a-c).
16 out of 32 benign cases were proven to be benign-
specific lesions. FNA was diagnostic in a single case with 
diagnosis of granulomatous inflammation and CNB in 
13 cases, accounting for 3.1% and 40.6% of all benign 
cases, respectively. The diagnostic accuracy of FNA and 
CNB for benign specific lesions was 6.3% and 81.3%, 
respectively. In this group, FNA and CNB showed 
discrepant results in 12 cases. Combination of both didn’t 
increase the diagnostic accuracy for detection of these 
types of lesions. In three cases which initial diagnosis 
were benign non-specific lesion, resection of one and 
the results of bacteriologic studies in combination with 
clinical findings were in keeping with organizing bacterial 
Table 1. Diagnostic Accuracy of FNA, CNB and Both with Application of IHC on CNB Samples in 73 Malignant 
intra-thoracic Lesions
Final diagnosis FNA CNB FNA+CNB
   (with application of 
   IHC on CNB)
Epithelial tumors
 Adenocarcinoma (n=35) 12 (34.3) 28 (80) 35 (100)
 Primary (n=27) --- --- 27 (100)
 Metastatic (n=8) --- --- 8 (100)
 Squamous cell ca. (n=24)* 13 (54.2) 20 (83.3) 20 (83.3)
 Typical carcinoid (n=1) 0 (0) 1 (100) 1 (100)
 Atypical Carcinoid (n=2)‡ 0 (0) 0 (0) 2 (100)
 Poorly Differentiated neuroendocrine carcinoma, small cell (small cell ca.) (n=5) 5 (100) 5 (100) 5 (100)
Non-Epithelial tumors   
 Sarcoma (n=2) 0 (0) 2 (100) 2 (100)
 Hodgkin Lymphoma (n=2) 1 (50) 2 (100) 2 (100)
 Primitive Neuroectodermal tumor (Small round malignant tumor) (n=2)† 2 (100) 1 (50) 2 (100)
- FNA, Fine-needle Aspiration; CNB, Core needle Biopsy; IHC, Immunohistochemical staining; -Data are given as number 
(percentage); *Four cases show mainly necrotic material or few atypical cells in FNA and CNB samples and final diagnosis was 
made on resection specimens; †Diagnosed as “Small Round Malignant Tumor” by FNA & CNB alone; ‡Erroneously diagnosed 
as “Squamous cell carcinoma” by CNB and “Non- small Cell Carcinoma” by FNA; ††Diagnosis of “Non-small cell Carcinoma” 
which made by FNA and CNB samples alone are not included
Table 2. Diagnostic Accuracy of FNA and CNB in 105 
intra-thoracic Lesions*
 Diagnosis
 Benign Malignant Indeterminate/ NFM
 Specific  Atypical† (non-specific
 Lesion   lesion)‡
FNA 1 (6.3) 63 (86.3) 10 (13.7) 31 (61.3)
CNB 13 (81.3) 68 (93.2) 4 (5.5) 19 (95)
FNA+CNB 13 (81.3) 69(94.5) 4 (5.5) 19 (100)
-FNA: Fine needle aspiration CNB: Core Needle Biopsy NFM: Negative 
for Malignancy; -Based on final diagnosis total number of malignant 
cases was 73 and benign lesions with a specific diagnosis were 16; *Data 
are given in “Number of cases (accuracy)”; †Cytological smears with 
atypical cells which didn’t full-fill the criteria of malignancy or histologic 
sections with mainly necrotic tissue containing few atypical cells in 
between; ‡Specimens with non-specific inflammation and/or fibrosis
Table 3. Diagnostic Accuracy of FNA, CNB and Both 
in Assessment of 32 Benign Lesions
Final Diagnosis FNA CNB FNA+CNB
NFM-Benign Specific Lesion (n=16)
 Granulomatous inflammation (n=5)* 1 (20) 5 (100) 5 (100)
 Organizing bacterial pneumonia (n=8) 0 (0) 5 (62.5) 5 (62.5)
 BOOP (n=1) 0 (0) 1 (100) 1 (100)
 Hydatid cyst (n=2) 0 (0) 2 (100) 2 (100)
Total (n=16) 1 (6.3) 13 (81.3) 13 (81.3)
NFM; Negative for malignancy, BOOP; Bronchiolitis obliterans 
organizing pneumonia; Data are given in number (percentage); 
*Including both caseating and non-caseating granulomatous lesions
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pneumonia (Table 3). The remaining 16 benign cases 
showed benign-nonspecific features in both specimen 
types. Although there was no definitive tool to define 
the specific pathological nature of lesions, they were 
considered to be benign because all patients underwent 
benign clinical and radiological courses. 
In this study, no false positive diagnosis of malignancy 
was observed with either technique. As previously 
reported, one false negative result was made in a case of 
primary adenocarcinoma with CNB technique.
Discussion
In 2008, lung cancer was the cause of 13% of all new 
cases of cancers and 18% of all cancer-related mortality, 
worldwide. The frequency of lung cancer in Iran is lower 
than in Europe and the USA (Jemal et al., 2011). On a 
nationwide scale, lung cancer ranks 7th or 8th in men 
and beyond 10th in women whereas on a global scale 
it ranks 1st and 4th in men and women, respectively 
(Emami et al., 2009; Mousavi et al., 2009). Despite 
lower frequency of lung cancer in Iran, the patients with 
this type of cancer have a short-term survival (Zahir and 
Mirtalebi, 2012) ranking 2nd in men and 3rd in women 
as the cause of cancer-related death (Mousavi et al., 
2009). Tobacco smoking alone is the most important risk 
factor for lung cancer as it accounts for more than 70% of 
pulmonary carcinomas (WHO, 2013). According to recent 
studies, squamous cell carcinoma is the most common 
histopathological subtype of bronchogenic carcinoma in 
Iran and Turkey (Demirci et al., 2013; Hajmanoochehri 
et al., 2014) 
Accurate pathological diagnosis is essential for 
selecting a suitable therapy for intrathoracic lesions. The 
skill of the operator, experience of the interpreter, and the 
nature of the lesion are among the factors that also affect 
diagnosis (Khouri et al., 1985; Spira et al., 2004; Kravtsov 
et al., 2014). FNA feasibility and availability justify the 
ready acceptance and wide use of this technique for lung 
masses. Previous studies have documented the reliability 
of FNA in the diagnosis of intrathoracic malignant tumors 
with reported accuracy rates of 80% to 95% (Moulton et 
al., 1993; Greif et al., 1999; Kim et al., 2002; Wallace et al., 
2004; Kravtsov et al. 2014). However, controversy exists 
about the overall value, complications, and limitations of 
FNA and CNB in assessing lung masses. In a systematic 
review included eleven studies in total the reported range 
of diagnosis accuracy of FNA and CNB were 79.7%-
91.8% and 89.0%-96.9% respectively. The range of 
accuracy for specific diagnosis of benign and malignant 
lesions were 40.4%-81.2% and 66.7%-93.2% by FNA 
and CNB respectively (Yao et al., 2012). Moreover, data 
that compare the use of both techniques performed in the 
same lesions are limited. 
Our results demonstrate that for malignant tumors, the 
diagnostic accuracy of FNA (86.3%) was acceptable but 
not generally comparable to that of CNB (93.2%), while 
FNA showed lower diagnostic value in comparison to 
CNB in the histological typing of epithelial malignant 
neoplasms (44.8% vs 80.6%). Moreover, CNB showed 
better diagnostic accuracy than FNA in evaluation of 
Figure 1. Fine-needle Aspiration Smears are 
Hypocellular Showing Isolated Small Round Tumoral 
Cells With High N/C Ratio, Dense Chromatin 
Pattern, Indistinct Nucleoli and Small amount of 
Pale Cytoplasm with Occasional Small Vacuoles. 
Background is dirty in favor of tumor diathesis, interpreted 
as “Small Round Malignant tumor”. (Papanicolaou, X400)
Figure 2. Concurrent Core Needle Biopsy Showing 
Sheet of Small Tumoral Cell in Associate with Large 
Areas of Necrosis Erroneously Interpreted as “ Small 
Cell Carcinoma”.( H&E, X400)
Figure 3. Immunohistochemical Staining of the Same 
Tumor (non necrotic area) Showing Strong Reactivity 
with CD99 Marker. The tumoral cells were negative for CK, 
Synaptophysin, Chromogranin, CD45 and myogenin. ( IHC 
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non-epithelial malignant neoplasms (83.3% vs 50%). 
Difficulty in aspirating mesenchymal neoplasms may 
result from entrapment of their cellular component 
in highly adhesive surrounding matrix, the fact that 
make CNB, an appropriate method for assessment of 
histologic architecture of the non-epithelial tumors and the 
performance of ancillary studies, which are essential for 
classifying of this type of neoplasms (Heilo et al., 1993; 
Pappa et al., 1996; Gong et al., 2006). 
In previous studies, FNA and CNB have been shown 
to be complementary in the diagnosis of malignant tumors 
(Moulton et al., 1993; Kim et al., 2002). Despite the better 
diagnostic yields of CNB in our study, only a single case 
of malignant epithelial tumor was diagnosed only by FNA, 
whereas combining FNA and CNB slightly improved 
the diagnostic accuracy. These results suggest that the 
combination of FNA and CNB could diagnose most cases 
of malignancy and provide almost equivalent results as 
open biopsy, mediastinoscopy, and thoracoscopy without 
the associated high morbidity and cost. 
The simplicity and cost-effectiveness of FNA could 
make it the primary procedure of choice for evaluating lung 
lesions, especially in patient with history of malignancy. 
In our study, although the tissue sampled by CNB allowed 
for the better architectural evaluation and classification 
of tumors, combination of FNA and CNB made better 
diagnostic yield in evaluation of small round malignant 
tumors. In addition, FNA material might be preferable to 
that acquired by CNB for microbiological studies. These 
cases manifest as Non-resolving pneumonias and therefore 
FNA can provide adequate material for appropriate 
microbiological and molecular studies, which are crucial 
in such cases.
Technical difficulties in aspirating representative 
material accounted for the majority of false negative 
results and indeterminate diagnoses made on FNA 
samples. Poor technique of smear preparation and fixation 
are other contributory factors. Immediate assessment by 
an on-site pathologist or cytopathologist improves the 
overall diagnostic yield by providing information about 
adequacy of FNA sample and if it is representative of the 
target lesion or not. In addition, it provide a background 
for better assessment of the sample by allowing triage of 
cases for appropriate workup (Conces et al., 1987; Austin 
et al., 1993; Wallace et al., 2004). 
Although FNA offers the reliable diagnosis of 
malignant lesions, its ability to identify a benign lesion is 
questionable. Specific diagnoses of benign lesions have 
varied from 12% to 50% in previous studies (Moulton et 
al., 1993; Greif et al., 1999; Gong et al., 2006). According 
to some reports, core biopsy is superior to FNAB in 
diagnosis of benign thoracic lesions, mediastinal tumors, 
determination of cancer cell-type and predicting cancer-
negative findings (Beslic et al., 2012). In the present study, 
diagnostic accuracy of FNA for benign specific lesions was 
very low (6.3%), while CNB improved the accuracy of a 
specific diagnosis for benign cases by 81.3%. In our study, 
FNA and CNB showed discrepant results in 12 cases. In 
addition, combination of both techniques didn’t increase 
the diagnostic accuracy for detection of these types of 
lesions. Indeed the difference between the results of these 
two procedures stands on the difference in capabilities 
in assessment of benign lesions. Unlike the diagnosis of 
malignant tumors for which individual cell morphology 
provide significant diagnostic information, diagnosis of 
benign specific lesions often depends on their histologic 
architecture, which frequently lost or destructed in FNA 
specimen.
Clinically and radiologically, benign lesions with 
benign cytologic and/or core biopsy findings might 
require follow-up only without surgical intervention, 
whereas a lesion with benign findings on FNA or CNB 
but clinical and/or radiologic evidence suggesting 
malignancy warrants re-biopsy or surgical excision 
(Gong et al., 2006). In our study, the interpretation of 
“NFM - nonspecific lesion” was reserved for those cases 
that were supported fully by negative clinical, radiologic 
and other findings. Four lesions were initially classified 
as atypical/ indeterminate by both methods but had 
clinical and radiologic features suspicious of malignancy 
were followed by surgical resection; all confirmed to 
have squamous cell carcinoma after histopathologic 
examination.
As mentioned earlier, FNA samples may have 
insufficient cells to interpret, but CNB mostly provided good 
tissue, which may not be sufficient as a pneumonectomy 
specimen. On these occasions, immunohistochemical 
methods could play an important role in the diagnostic 
evaluation of biopsy samples (Montezuma et al., 2013). 
For example, squamous cell carcinomas may form gland-
like structures similar to adenocarcinomas, which are 
easily diagnosed by using a small immunohistochemical 
panel. In our study, few cases had surgical tissue 
specimens available and most final diagnoses were made 
with the immunohistochemical work up of CNB samples.
CT-guided transthoracic needle biopsy is generally 
regarded as a safe procedure with limited morbidity and 
extremely rare mortality. Complications of transthoracic 
needle biopsy include pneumothorax, hemoptysis, 
hemothorax, infection, and air embolism, with the most 
common complication as pneumothorax (Boskovic et al., 
2014). Risk factors for the development of biopsy-related 
pneumothorax include the presence of chronic obstructive 
pulmonary disease (COPD), small lesion size, a long 
needle path, repeated pleural puncture, and the absence 
of a history of ipsilateral surgery (Dennie et al., 2001)
In conclusion, accurate pathological diagnosis is 
imperative for determining an optimal therapy for 
intrathoracic lesions. FNA and CNB offer different 
advantages and limitations for diagnosing lung lesions. 
Our findings suggest that FNA is comparable to CNB 
in the diagnosis of malignant epithelial lesions whereas 
diagnostic accuracy of CNB for nonepithlial malignant 
neoplasms is superior to FNA. Combining FNA and 
CNB methods slightly improves the diagnostic accuracy 
for malignant lesions. We suppose that Combination of 
FNA and CNB should be the preferred approach when 
benign lesions are suspected. Further, for the histological 
typing of tumors and for examining tumor origin, an 
immunohistochemical work up plays an important role.
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